In addition, activin-A levels have been associated with metabolic syndrome in adults [55], with cardiometabolic disturbances that may lead to heart failure, myocardial fibrosis via activation of the ERK1/2 and p38-MAPK pathways [56], and myocardial infarction. Here, MAPK3 is linked to heart failure.